A common feature of AML is the deregulation of signal transduction pathways that are often networked and support the proliferation and survival of leukemic cells, including RAF/MEK/ERK, PI3K/Akt, and the receptor tyrosine kinase FLT3 [33,34,35]. This evidence concerns the gene RAF1 and acute myeloid leukemia.